Ethan Basch
Biographic Data
| ID | 5546039 |
|---|---|
| NAME | Ethan Basch |
| GIVEN NAMES | Ethan |
| FAMILY NAME | Basch |
| SIGNATURE | BASCH E |
| AFFILIATIONS | University of North Carolina at Chapel Hill |
| ORCID | 0000-0003-3813-9318 |
| VERIFIED | Yes |
| TOTAL WORKS | 17 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 17 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Quality of life during electronic patient-reported outcome (ePRO) monitoring in thoracic surgery patients
Patients undergoing thoracic surgery experience high symptom burden and negative impacts on postoperative health-related quality of life (HRQOL). Remote symptom monitoring using electronic patient-reported outcomes (ePROs) in other patient populations improves HRQOL but may increase workload for surgical providers. We evaluated the feasibility of ePRO use by thoracic surgery patients and providers as well as its impact on HRQOL. In this single ce…
Jama Health Forum Peer Reviewers in 2023
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
gov: NCT03249090 (AFT-39), NCT02158637 (MC1091)
Truth and dare
This study does not support the hypothesis that patients systematically bias their PROM responses if they know that clinicians will see their results. These findings support using PROMs in clinical practice as a valid mechanism to promote patient-centered care
Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)
Jama Health Forum Peer Reviewers in 2022
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period
A 24-hour recall period for PRO-CTCAE items has acceptable measurement properties and can inform day-to-day variations in symptomatic AEs when daily PRO-CTCAE administration is implemented in a clinical trial
Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
In this cohort study, among states adopting oncology parity laws between 2013 and 2017, mean out-of-pocket spending per OAM prescription fill and mean health plan spending among OAM users was similar in states with and without caps. However, enrollees in states with parity plus out-of-pocket caps had greater reductions in out-of-pocket spending among the highest spenders. Caps may offer improved financial protection for the highest spenders witho…
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and Comet-2
gov Identifiers: NCT02066181 (Alliance A091105); NCT01522443 (COMET-2)
Racial differences in user experiences and perceived value of electronic symptom monitoring in a cohort of black and white bladder and prostate cancer patients
Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery
INTRODUCTION: Patient-reported outcome (PRO) measures used during cancer care delivery improve communication about symptoms between patients and clinicians and reduce service utilization for uncontrolled symptoms. However, uptake of PROs in routine cancer care has been slow. In this paper, we describe stakeholder engagement activities used to overcome barriers to implementing PROs. Implementation occurred in 2 study settings: PROs completed in th…
The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice
Evaluation of pedometry as a patient-centered outcome in patients undergoing hematopoietic cell transplant (HCT)
Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research
BACKGROUND: The goal of comparative effectiveness research (CER) is to explain the differential benefits and harms of alternate methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. To inform decision making, information from the patient's perspective that reflects outcomes that patients care about are needed and can be collected rigorously using appropriate patient-reported outcomes (PRO). It c…
Reliability of adverse symptom event reporting by clinicians
The king’s foot of patient-reported outcomes
There was a consensus that important research still needs to be performed in order develop and refine high-quality PRO measures and statistical methods to analyze and model change in PRO constructs
No prominent works on this page.
Reliability of adverse symptom event reporting by clinicians
The king’s foot of patient-reported outcomes
There was a consensus that important research still needs to be performed in order develop and refine high-quality PRO measures and statistical methods to analyze and model change in PRO constructs
The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research
BACKGROUND: The goal of comparative effectiveness research (CER) is to explain the differential benefits and harms of alternate methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. To inform decision making, information from the patient's perspective that reflects outcomes that patients care about are needed and can be collected rigorously using appropriate patient-reported outcomes (PRO). It c…
Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Evaluation of pedometry as a patient-centered outcome in patients undergoing hematopoietic cell transplant (HCT)
The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice
Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery
INTRODUCTION: Patient-reported outcome (PRO) measures used during cancer care delivery improve communication about symptoms between patients and clinicians and reduce service utilization for uncontrolled symptoms. However, uptake of PROs in routine cancer care has been slow. In this paper, we describe stakeholder engagement activities used to overcome barriers to implementing PROs. Implementation occurred in 2 study settings: PROs completed in th…
Racial differences in user experiences and perceived value of electronic symptom monitoring in a cohort of black and white bladder and prostate cancer patients
Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
In this cohort study, among states adopting oncology parity laws between 2013 and 2017, mean out-of-pocket spending per OAM prescription fill and mean health plan spending among OAM users was similar in states with and without caps. However, enrollees in states with parity plus out-of-pocket caps had greater reductions in out-of-pocket spending among the highest spenders. Caps may offer improved financial protection for the highest spenders witho…
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and Comet-2
gov Identifiers: NCT02066181 (Alliance A091105); NCT01522443 (COMET-2)
Jama Health Forum Peer Reviewers in 2022
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period
A 24-hour recall period for PRO-CTCAE items has acceptable measurement properties and can inform day-to-day variations in symptomatic AEs when daily PRO-CTCAE administration is implemented in a clinical trial
Jama Health Forum Peer Reviewers in 2023
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
gov: NCT03249090 (AFT-39), NCT02158637 (MC1091)
Truth and dare
This study does not support the hypothesis that patients systematically bias their PROM responses if they know that clinicians will see their results. These findings support using PROMs in clinical practice as a valid mechanism to promote patient-centered care
Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)
Quality of life during electronic patient-reported outcome (ePRO) monitoring in thoracic surgery patients
Patients undergoing thoracic surgery experience high symptom burden and negative impacts on postoperative health-related quality of life (HRQOL). Remote symptom monitoring using electronic patient-reported outcomes (ePROs) in other patient populations improves HRQOL but may increase workload for surgical providers. We evaluated the feasibility of ePRO use by thoracic surgery patients and providers as well as its impact on HRQOL. In this single ce…
Medicine (16 works) · Nursing (9 works) · Public health (8 works) · Quality of Life Research (8 works) · Internal Medicine (7 works) · Cancer survivorship and care (6 works) · Quality of life (healthcare (6 works) · Adverse effect (5 works) · Health Systems, Economic Evaluations, Quality of Life (5 works) · Political science (5 works)